awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q41349963-5C12E2A3-0A30-4CB8-AF77-4E69223F932D
Q41349963-5C12E2A3-0A30-4CB8-AF77-4E69223F932D
BestRank
Statement
http://www.wikidata.org/entity/statement/Q41349963-5C12E2A3-0A30-4CB8-AF77-4E69223F932D
New diagnostic criteria for neurocysticercosis: Reliability and validity.
P2860
Q41349963-5C12E2A3-0A30-4CB8-AF77-4E69223F932D
BestRank
Statement
http://www.wikidata.org/entity/statement/Q41349963-5C12E2A3-0A30-4CB8-AF77-4E69223F932D
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
25943b33ddb866acc1a4513d4727d30c105e9ad1
P2860
Albendazole trial at 15 or 30 mg/kg/day for subarachnoid and intraventricular cysticercosis.